Related Experiment Video
Updated: Jul 14, 2026

10:01
Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
Published on: July 10, 2012
A new murine model for bronchiolitis obliterans post-bone marrow transplant
Angela Panoskaltsis-Mortari1, Kevin V Tram, Andrew P Price
1University of Minnesota, Department of Pediatrics, Division of Hematology/Oncology, Minneapolis, MN 55455, USA. panos001@umn.edu
Summary
A new mouse model for bronchiolitis obliterans (BO) was developed to study late-onset lung disease after hematopoietic stem cell transplant. This model shows airway obstruction and inflammation, aiding research into therapeutic interventions for BO.
Area of Science:
- * Immunology and Transplantation Science
- * Pulmonary Medicine and Pathology
Background:
- * Bronchiolitis obliterans (BO) is a significant complication following lung transplantation and hematopoietic stem cell transplant (HSCT).
- * Current mouse models do not adequately represent the late-onset pulmonary complications seen in patients, hindering therapeutic development.
Purpose of the Study:
- * To develop a novel mouse model that accurately replicates bronchiolitis obliterans (BO).
- * To facilitate the study of BO's onset and progression, particularly in the context of late complications after HSCT.
Main Methods:
- * Establishment of a mouse model using lethally conditioned recipients receiving T-cell-depleted allogeneic bone marrow (BM) with a sublethal dose of allogeneic T cells.
- * Assessment of lung pathology, inflammation markers, airway function, and graft-versus-host disease (GVHD) at two months post-transplant.
Main Results:
- * The developed model exhibited extensive perivascular and peribronchiolar inflammation in the lungs, including T cells, B cells, macrophages, neutrophils, and fibroblasts.
- * Histological analysis confirmed airway obstruction consistent with BO, along with epithelial cell changes and evidence of pulmonary edema and fibrosis.
- * Mice displayed impaired lung function (high airway resistance, low compliance) and early increases in inflammatory mediators.
Conclusions:
- * The established mouse model effectively mimics late-onset BO following allogeneic HSCT.
- * This model is valuable for investigating BO associated with chronic GVHD and improving outcomes in lung transplant recipients.
